COMPANY INSIGHT

Sponsored by Capsugel

Lonza Pharma & Biotech – Capsule Delivery Solutions

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally

For more than 100 years, biopharmaceutical companies have relied on the quality, consistency and functional innovations Capsugel® has delivered; today we produces more than 200 billion capsules in over 100 countries.

Building on our history of innovation in polymer science and capsule engineering, Capsule Delivery Solutions continues to launch ground-breaking capsule designs and equipment technologies that are improving drug development and delivery. Whether you’re looking to formulate new products or enhance an existing line, we have the right capsule to help you bring improved products to market faster. With a diverse portfolio including HPMC, Dry Powder Inhalation capsules or specialized clinical capsules, we are a global leader in capsule development and manufacturing, bringing unmatched products and technical support to our worldwide customer base.

Capsule Delivery Solutions Quality  

From the purchase of key raw materials to the manufacturing, packaging and delivering of finished products, Capsule Delivery Solutions works to ensure the safety and quality of capsules we supply to pharmaceutical customers around the world.

As key elements of our quality commitment, Capsugel is investing in Regulatory Compliance Monitoring Programs that anticipates and proactively responds to the continuously evolving global food-safety standards and maintains a robust Quality System, from sourcing of our ingredients to the distribution of our products, that is compliant with all applicable standards.

Capsule Delivery Solutions offers  

High quality empty capsules:

  • Immediate release: Coni-Snap® Gelatin, Vcaps® Plus, Plantcaps®
  • Targeted & Modified release: Vcaps® Enteric, DUOCAP®
  • Dry Powder Inhalation capsules: Gelatin: Coni-Snap® Gelatin and Coni-Snap® Gelatin-PEG, HPMC: Vcaps® and Vcaps® Plus
  • Preclinical and clinical development capsules: PCcaps®, DBcaps®
  • Patient Centric capsules: Coni-Snap® Sprinkle
  • Life Cycle Management solutions: Press-Fit®, XPress-Fit®

Innovative and tailored services:

Go to article: Home | Saving face: PR in pharma Go to article: In this issueGo to article: Emirates SkyCargoGo to article: ContentsGo to article: Hapa Company Insight Go to article: Owen MumfordGo to article: NewsGo to article: Dupont PharmaceuticalsGo to article: Accurate Biometrics Company Insight Go to article: Accurate BiometricsGo to article: The pharma industry briefingGo to article: Scandinavian Health Ltd.Go to article: Gerteis Company InsightGo to article: GerteisGo to article: Coughs and sneezes spread diseases: charting the development of flu vaccinesGo to article: Swiss WorldCargoGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: ‘Don’t put baby in the corner’: overcoming challenges in paediatric drug developmentGo to article: Qatar AirwaysGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: Debate: should countries bring critical drug production home?Go to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Capsugel Company Insight Go to article: Beyond Viagra Town: profiling the Irish pharma industryGo to article: Daiichi JitsugyoGo to article: TSS Company Insight Go to article: TSSGo to article: Recurrent miscarriage: could this devastating condition have a simple cure?Go to article: LB Bohle Company Insight Go to article: LB BohleGo to article: Public image limited: the role of PR in pharmaGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: Q&A: Gavi alliance talks immunising 300 million people Go to article: Spirax Sarco Company Insight Go to article: Spirax SarcoGo to article: Bias remorse: are cancer drug trials clear enough on outcomes?Go to article: Zenatek Go to article: B&W TekGo to article: Deals in brief powered by GlobalDataGo to article: Centaur Clinical Insight Go to article: Centaur ClinicalGo to article: The key list powered by GlobalDataGo to article: AlpexGo to article: PfanstiehlGo to article: EventsGo to article: MimotopesGo to article: NymiGo to article: Next issue